112 related articles for article (PubMed ID: 9373594)
21. The testis. I. The normal testis.
SNIFFEN RC
Arch Pathol (Chic); 1950 Sep; 50(3):259-84. PubMed ID: 15433699
[No Abstract] [Full Text] [Related]
22. Increase of blood fibrinolytic activity by testosterone.
FEARNLEY GR; CHAKRABARTI R
Lancet; 1962 Jul; 2(7247):128-32. PubMed ID: 13891922
[No Abstract] [Full Text] [Related]
23. The microdetermination of testosterone in human spermatic vein blood.
HOLLANDER N; HOLLANDER VP
J Clin Endocrinol Metab; 1958 Sep; 18(9):966-71. PubMed ID: 13575513
[No Abstract] [Full Text] [Related]
24. The male climacterium.
Vermeulen A
Ann Med; 1993 Dec; 25(6):531-4. PubMed ID: 8292301
[TBL] [Abstract][Full Text] [Related]
25. The determination of bio-available testosterone.
Wheeler MJ
Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():345-57. PubMed ID: 7486793
[No Abstract] [Full Text] [Related]
26. A clinical and endocrine study of mesterolone in secondary impotence.
Cooper AJ
J Psychosom Res; 1980; 24(5):275-9. PubMed ID: 7205715
[No Abstract] [Full Text] [Related]
27. Age differences in serum androgen levels in normal adult males.
Purifoy FE; Koopmans LH; Mayes DM
Hum Biol; 1981 Dec; 53(4):499-511. PubMed ID: 7199020
[No Abstract] [Full Text] [Related]
28. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.
Skakkebaek NE; Bancroft J; Davidson DW; Warner P
Clin Endocrinol (Oxf); 1981 Jan; 14(1):49-61. PubMed ID: 7014044
[TBL] [Abstract][Full Text] [Related]
29. Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients.
Luisi M; Franchi F
J Endocrinol Invest; 1980; 3(3):305-8. PubMed ID: 7000879
[TBL] [Abstract][Full Text] [Related]
30. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.
Kwan M; Greenleaf WJ; Mann J; Crapo L; Davidson JM
J Clin Endocrinol Metab; 1983 Sep; 57(3):557-62. PubMed ID: 6874890
[TBL] [Abstract][Full Text] [Related]
31. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.
Bremner WJ; Vitiello MV; Prinz PN
J Clin Endocrinol Metab; 1983 Jun; 56(6):1278-81. PubMed ID: 6841562
[TBL] [Abstract][Full Text] [Related]
32. Changes in erectile responsiveness during androgen replacement therapy.
Bancroft J; Wu FC
Arch Sex Behav; 1983 Feb; 12(1):59-66. PubMed ID: 6838355
[TBL] [Abstract][Full Text] [Related]
33. Semen characteristics as a function of age in 833 fertile men.
Schwartz D; Mayaux MJ; Spira A; Moscato ML; Jouannet P; Czyglik F; David G
Fertil Steril; 1983 Apr; 39(4):530-5. PubMed ID: 6832409
[TBL] [Abstract][Full Text] [Related]
34. Reproductive functions in young fathers and grandfathers.
Nieschlag E; Lammers U; Freischem CW; Langer K; Wickings EJ
J Clin Endocrinol Metab; 1982 Oct; 55(4):676-81. PubMed ID: 6809780
[TBL] [Abstract][Full Text] [Related]
35. A specification of marital fertility by parents' age, age at marriage and marital duration.
Mineau GP; Trussell J
Demography; 1982 Aug; 19(3):335-50. PubMed ID: 6749566
[TBL] [Abstract][Full Text] [Related]
36. The gonadotropin-suppressive activity of androgen is increased in elderly men.
Winters SJ; Sherins RJ; Troen P
Metabolism; 1984 Nov; 33(11):1052-9. PubMed ID: 6436639
[TBL] [Abstract][Full Text] [Related]
37. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men.
Neaves WB; Johnson L; Porter JC; Parker CR; Petty CS
J Clin Endocrinol Metab; 1984 Oct; 59(4):756-63. PubMed ID: 6434579
[TBL] [Abstract][Full Text] [Related]
38. New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens.
Labrie F; Dupont A; Belanger A; Lacoursiere Y; Raynaud JP; Husson JM; Gareau J; Fazekas AT; Sandow J; Monfette G
Prostate; 1983; 4(6):579-94. PubMed ID: 6415630
[TBL] [Abstract][Full Text] [Related]
39. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study.
O'Carroll R; Bancroft J
Br J Psychiatry; 1984 Aug; 145():146-51. PubMed ID: 6380630
[TBL] [Abstract][Full Text] [Related]
40. The control of deviant sexual behaviour by drugs. I. Behavioural changes following oestrogens and anti-androgens.
Bancroft J; Tennent G; Loucas K; Cass J
Br J Psychiatry; 1974 Sep; 125(0):310-5. PubMed ID: 4607733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
